Wednesday 15 February 2012

JumpStart Invests $250,000 in Milo Biotechnology -- CLEVELAND, Feb. 14, 2012 /PRNewswire/ --

JumpStart Invests $250,000 in Milo Biotechnology -- CLEVELAND, Feb. 14, 2012 /PRNewswire/ --: "CLEVELAND, Feb. 14, 2012 /PRNewswire/ -- Milo Biotechnology will receive $250,000 from JumpStart Inc., a nonprofit investing intensive business assistance and some capital into early stage Northeast Ohio-based tech companies. A clinical stage startup developing a therapy to increase muscle strength and improve the quality of life of muscular dystrophy patients, Milo is the 61st company in JumpStart's portfolio. "There are limited treatment options for muscular dystrophy and approved therapies are inadequate or can cause significant side effects," says JumpStart's Mike Lang. "Since most muscular dystrophy patients are children, the medical community is interested in a safer and more targeted therapy.""

'via Blog this'

No comments:

Post a Comment